Taiwan Advance Bio-Pharmaceutical Inc. 4186.TWO Stock
Taiwan Advance Bio-Pharmaceutical Inc. Price Chart
Taiwan Advance Bio-Pharmaceutical Inc. 4186.TWO Financial and Trading Overview
Contents
| Taiwan Advance Bio-Pharmaceutical Inc. stock price | 15.15 TWD |
| Previous Close | 18.75 TWD |
| Open | 19.1 TWD |
| Bid | 18.7 TWD x 0 |
| Ask | 19.05 TWD x 0 |
| Day's Range | 18.7 - 19.1 TWD |
| 52 Week Range | 14.2 - 21.8 TWD |
| Volume | 136.93K TWD |
| Avg. Volume | 240.41K TWD |
| Market Cap | 1.71B TWD |
| Beta (5Y Monthly) | 0.839041 |
| PE Ratio (TTM) | 476.25 |
| EPS (TTM) | -0.46 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4186.TWO Valuation Measures
| Enterprise Value | 1.81B TWD |
| Trailing P/E | 476.25 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.387494 |
| Price/Book (mrq) | 7.00883 |
| Enterprise Value/Revenue | 5.683 |
| Enterprise Value/EBITDA | 56.944 |
Trading Information
Taiwan Advance Bio-Pharmaceutical Inc. Stock Price History
| Beta (5Y Monthly) | 0.839041 |
| 52-Week Change | 12.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.8 TWD |
| 52 Week Low | 14.2 TWD |
| 50-Day Moving Average | 19.81 TWD |
| 200-Day Moving Average | 17.98 TWD |
4186.TWO Share Statistics
| Avg. Volume (3 month) | 240.41K TWD |
| Avg. Daily Volume (10-Days) | 181.44K TWD |
| Shares Outstanding | 90M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.99% |
| Operating Margin (ttm) | 2.64% |
| Gross Margin | 60.51% |
| EBITDA Margin | 9.98% |
Management Effectiveness
| Return on Assets (ttm) | 0.73% |
| Return on Equity (ttm) | 1.30% |
Income Statement
| Revenue (ttm) | 318.24M TWD |
| Revenue Per Share (ttm) | 3.54 TWD |
| Quarterly Revenue Growth (yoy) | 28.79% |
| Gross Profit (ttm) | N/A |
| EBITDA | 31.76M TWD |
| Net Income Avi to Common (ttm) | 3.17M TWD |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 158.56M TWD |
| Total Cash Per Share (mrq) | 1.76 TWD |
| Total Debt (mrq) | 279.7M TWD |
| Total Debt/Equity (mrq) | 114.33 TWD |
| Current Ratio (mrq) | 1.07 |
| Book Value Per Share (mrq) | 2.718 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20593000 TWD |
| Levered Free Cash Flow (ttm) | -11428500 TWD |
Profile of Taiwan Advance Bio-Pharmaceutical Inc.
| Country | Taiwan |
| State | N/A |
| City | New Taipei City |
| Address | No. 25, Kangning Street |
| ZIP | 22180 |
| Phone | 886 2 2692 6222 |
| Website | https://www.biotest.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 154 |
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry. The company provides food safety and Covid-19 diagnostic testing products. It also offers abused drugs rapid tests; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. In addition, the company develops Hb4Cord to treat hematopoietic and genetic diseases; and provides cell banking services. Taiwan Advance Bio-Pharmaceutical Inc. was founded in 1989 and is based in New Taipei City, Taiwan.
Q&A For Taiwan Advance Bio-Pharmaceutical Inc. Stock
What is a current 4186.TWO stock price?
Taiwan Advance Bio-Pharmaceutical Inc. 4186.TWO stock price today per share is 15.15 TWD.
How to purchase Taiwan Advance Bio-Pharmaceutical Inc. stock?
You can buy 4186.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Taiwan Advance Bio-Pharmaceutical Inc.?
The stock symbol or ticker of Taiwan Advance Bio-Pharmaceutical Inc. is 4186.TWO.
Which industry does the Taiwan Advance Bio-Pharmaceutical Inc. company belong to?
The Taiwan Advance Bio-Pharmaceutical Inc. industry is Biotechnology.
How many shares does Taiwan Advance Bio-Pharmaceutical Inc. have in circulation?
The max supply of Taiwan Advance Bio-Pharmaceutical Inc. shares is 90M.
What is Taiwan Advance Bio-Pharmaceutical Inc. Price to Earnings Ratio (PE Ratio)?
Taiwan Advance Bio-Pharmaceutical Inc. PE Ratio is now.
What was Taiwan Advance Bio-Pharmaceutical Inc. earnings per share over the trailing 12 months (TTM)?
Taiwan Advance Bio-Pharmaceutical Inc. EPS is -0.46 TWD over the trailing 12 months.
Which sector does the Taiwan Advance Bio-Pharmaceutical Inc. company belong to?
The Taiwan Advance Bio-Pharmaceutical Inc. sector is Healthcare.